Home › Funds › CLARK ESTATES INC/NY › ECML
CLARK ESTATES INC/NY position in ECML
Euclidean Fundamental Value Et
CLARK ESTATES INC/NY reported holding 1,587,382 shares of ECML (Euclidean Fundamental Value Et) in its Q3 2026 13F filing — a position valued at US$62.3M, representing 14.48% of its reported portfolio and ranking #1 among its reported holdings. CLARK ESTATES INC/NY has disclosed ECML holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How CLARK ESTATES INC/NY's ECML position evolved
CLARK ESTATES INC/NY first disclosed a stake in ECML in Q3 2023 at 3,358,841 shares (US$94.0M). The position peaked in Q1 2024 at 3,363,441 shares, worth US$115.8M. Across 13 filings, CLARK ESTATES INC/NY increased the stake 0 time(s), trimmed it 8 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 1,587,382 shares valued at US$62.3M — a reduction of -135,400 shares quarter over quarter.. Notable position changes include a 25% trim in Q3 2025 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.36M | $94.03M | New |
| Q4 2023 | 3.35M | $104.77M | Hold |
| Q1 2024 | 3.36M | $115.76M | Hold |
| Q2 2024 | 3.36M | $106.77M | Hold |
| Q3 2024 | 3.34M | $114.21M | Reduce |
| Q4 2024 | 3.32M | $105.35M | Hold |
| Q1 2025 | 3.15M | $96.57M | Reduce |
| Q2 2025 | 3.09M | $95.04M | Reduce |
| Q3 2025 | 2.31M | $76.91M | Reduce |
| Q4 2025 | 2.29M | $76.46M | Reduce |
| Q1 2026 | 2.12M | $77.00M | Reduce |
| Q2 2026 | 1.72M | $66.65M | Reduce |
| Q3 2026 | 1.59M | $62.33M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ECML and 13F data
ECML (Euclidean Fundamental Value Et) is a company whose sector is not yet classified in our data. 6 other funds we track also report a position in ECML. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on CLARK ESTATES INC/NY
FAQ
How long has CLARK ESTATES INC/NY held ECML?
CLARK ESTATES INC/NY has disclosed ECML holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is CLARK ESTATES INC/NY's current position in ECML?
As of Q3 2026, CLARK ESTATES INC/NY holds 1.59M shares of ECML (Euclidean Fundamental Value Et), valued at $62.33M, representing 14.48% of its reported portfolio and ranking #1.
Has CLARK ESTATES INC/NY been buying or selling ECML?
In the latest 13F filing (Q3 2026), CLARK ESTATES INC/NY reduced its position in ECML. The position peaked in Q1 2024 at 3.36M shares.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.